Australia quick Hazlewood ruled out of Ashes after injury setback
Australia fast bowler Josh Hazlewood was on Tuesday ruled out of the rest of the Ashes against England following an injury setback.
Read moreMajor Japan quake leaves 30 injured
A big quake off northern Japan left at least 30 injured, authorities said Tuesday, damaging roads and leaving thousands without power in freezing temperatures.
Read moreRising living costs dim holiday sparkle for US households
At a Christmas market outside the US capital, festive cheer alone hasn't been enough to drive affordability worries out of shoppers' minds -- as American households contend with creeping inflation this holiday season.
Read moreData centers: a view from the inside
The expansion of data centers to power the AI boom has more people wondering: what exactly is in a data center?
Read moreLong-serving Russian envoy to North Korea dies
Russia's ambassador to North Korea, who spent decades working in the reclusive state and recently oversaw a boom in ties between the two countries, died over the weekend, Moscow said Monday.
Read moreGrande Portage Closes C$5Million Equity Raise
Not for distribution to United States newswire services or for dissemination in the United States.
Read moreTechmer PM Joins Formerra's Portfolio in North America
Formerra will distribute Techmer PM color masterbatches, high-performance additives, and pre-colored compounds across the U.S., Canada, and Mexico.
Read moreBioNxt Advances "Melt in Your Mouth" Cladribine Formulation to Improve Treatment for MS Patients with Dysphagia
VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is advancing the development of a next-generation "Melt in Your Mouth" cladribine formulation, built on the Company's proprietary oral dissolvable film (ODF) drug-delivery system. The technology is designed for rapid, sublingual (under-the-tongue) absorption of medication and aims to improve treatment access and comfort for people living with multiple sclerosis (MS). BioNxt's lead program, BNT23001, is being developed as a swallow-free alternative to cladribine tablets, which generated USD 1.28 billion in global sales in 2024.
Read moreReddit says Australia's under-16 social media ban 'legally erroneous'
Online discussion site Reddit on Tuesday condemned Australia's imminent social media ban for under-16s as "legally erroneous" but said it would comply with the landmark crackdown.
Read more10 reported hurt after big Japan quake, warning of more tremors
At least 10 people were reported injured on Tuesday but there appeared to be no major damage after a big quake rocked northern Japan and triggered tsunami waves up to 70 centimetres (28 inches) high.
Read moreIn The News